Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The cash and debt free consideration value is €370 million.
EC grants conditional marketing authorization based on the EFFISAYIL trial
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
The new production line is equipped with the latest advanced manufacturing system to produce quality products of Alkaloids & APIs used in a wide range of pharmaceutical applications
The approval further strengthens the Potassium Chloride franchise for the company.
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
Prime Minister Narendra Modi attended an event marking the 100th robotic-assisted surgical system installation at U. N. Mehta Institute of Cardiology, Ahmedabad.
First and only next-generation protein-based adjuvanted COVID-19 booster approved in Europe
Subscribe To Our Newsletter & Stay Updated
